These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29982797)

  • 21. Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis?
    Kilic G; Kilic E; Ozgocmen S
    Int J Rheum Dis; 2017 Sep; 20(9):1201-1211. PubMed ID: 27309497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis.
    Baraliakos X; Baerlecken N; Witte T; Heldmann F; Braun J
    Ann Rheum Dis; 2014 Jun; 73(6):1079-82. PubMed ID: 23644552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing smoking intensity is associated with increased disease activity in axial spondyloarthritis.
    Zhao S; Challoner B; Khattak M; Moots RJ; Goodson NJ
    Rheumatol Int; 2017 Feb; 37(2):239-244. PubMed ID: 27815702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohort.
    van den Berg R; de Hooge M; Rudwaleit M; Sieper J; van Gaalen F; Reijnierse M; Landewé R; Huizinga T; van der Heijde D
    Ann Rheum Dis; 2013 Oct; 72(10):1646-53. PubMed ID: 23139266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in serum SP-D levels between German and Japanese subjects are associated with SFTPD gene polymorphisms.
    Horimasu Y; Hattori N; Ishikawa N; Tanaka S; Bonella F; Ohshimo S; Guzman J; Costabel U; Kohno N
    BMC Med Genet; 2014 Jan; 15():4. PubMed ID: 24400879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between the surfactant protein D (SFTPD) gene and subclinical carotid artery atherosclerosis.
    Sorensen GL; Bladbjerg EM; Steffensen R; Tan Q; Madsen J; Drivsholm T; Holmskov U
    Atherosclerosis; 2016 Mar; 246():7-12. PubMed ID: 26748346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SP-D polymorphisms and the risk of COPD.
    Shakoori TA; Sin DD; Bokhari SN; Ghafoor F; Shakoori AR
    Dis Markers; 2012; 33(2):91-100. PubMed ID: 22846212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased Th17 and Th1 cells in the peripheral blood of patients with early non-radiographic axial spondyloarthritis: a marker of disease activity in HLA-B27⁺ patients.
    Bautista-Caro MB; Arroyo-Villa I; Castillo-Gallego C; de Miguel E; Peiteado D; Puig-Kröger A; Martín-Mola E; Miranda-Carús ME
    Rheumatology (Oxford); 2013 Feb; 52(2):352-62. PubMed ID: 23065314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive correlation between inflammation on sacroiliac joint MRI and serum C-terminal telopeptide of type-I collagen in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis.
    Kang KY; Jung JY; Hong YS; Ju JH; Park SH
    Clin Exp Rheumatol; 2017; 35(3):415-422. PubMed ID: 27974096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D.
    Leth-Larsen R; Garred P; Jensenius H; Meschi J; Hartshorn K; Madsen J; Tornoe I; Madsen HO; Sørensen G; Crouch E; Holmskov U
    J Immunol; 2005 Feb; 174(3):1532-8. PubMed ID: 15661913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA.
    van der Heijde D; Dougados M; Landewé R; Sieper J; Maksymowych WP; Rudwaleit M; Van den Bosch F; Braun J; Mease PJ; Kivitz AJ; Walsh J; Davies O; Bauer L; Hoepken B; Peterson L; Deodhar A
    Rheumatology (Oxford); 2017 Sep; 56(9):1498-1509. PubMed ID: 28498975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms in the human surfactant protein-D (SFTPD) gene: strong evidence that serum levels of surfactant protein-D (SP-D) are genetically influenced.
    Heidinger K; König IR; Bohnert A; Kleinsteiber A; Hilgendorff A; Gortner L; Ziegler A; Chakraborty T; Bein G
    Immunogenetics; 2005 Apr; 57(1-2):1-7. PubMed ID: 15700120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cartilage collagen type II seromarker patterns in axial spondyloarthritis and psoriatic arthritis: associations with disease activity, smoking and HLA-B27.
    Munk HL; Gudmann NS; Christensen AF; Ejstrup L; Sorensen GL; Loft AG; Bay-Jensen AC; Siebuhr AS; Junker P
    Rheumatol Int; 2016 Apr; 36(4):541-9. PubMed ID: 26620690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
    Pedersen SJ; Sørensen IJ; Garnero P; Johansen JS; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Lambert R; Hansen A; Østergaard M
    Ann Rheum Dis; 2011 Aug; 70(8):1375-81. PubMed ID: 21551511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers, imaging and disease activity indices in patients with early axial spondyloarthritis: the Italian arm of the SpondyloArthritis-Caught-Early (SPACE) Study.
    Lorenzin M; Ortolan A; Vio S; Favero M; Oliviero F; Zaninotto M; Cosma C; Lacognata C; Punzi L; Ramonda R
    Reumatismo; 2017 Aug; 69(2):65-74. PubMed ID: 28776360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and drug survival of anti-tumour necrosis factor-alpha therapies in patients with non-radiographic axial spondyloarthritis: an observational cohort study from Southern Sweden.
    Gulfe A; Kapetanovic MC; Kristensen LE
    Scand J Rheumatol; 2014; 43(6):493-7. PubMed ID: 25145283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcohol and disease activity in axial spondyloarthritis: a cross-sectional study.
    Zhao S; Thong D; Duffield SJ; Hughes D; Goodson NJ
    Rheumatol Int; 2018 Mar; 38(3):375-381. PubMed ID: 29322342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No diagnostic utility of antibody patterns against Klebsiella pneumoniae capsular serotypes in patients with axial spondyloarthritis vs. patients with non-specific low back pain: a cross-sectional study.
    Hermansen LT; Loft AG; Christiansen AA; Munk HL; Gilbert L; Jurik AG; Arnbak B; Manniche C; Weber U; Østergaard M; Pedersen SJ; Barington T; Junker P; Hørslev-Petersen K; Hendricks O
    Scand J Rheumatol; 2017 Jul; 46(4):296-302. PubMed ID: 27600931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.
    Protopopov M; Sieper J; Haibel H; Listing J; Rudwaleit M; Poddubnyy D
    Arthritis Res Ther; 2017 Oct; 19(1):240. PubMed ID: 29065931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimeric and trimeric subunit SP-D are interconvertible structures with distinct ligand interaction.
    Sorensen GL; Hoegh SV; Leth-Larsen R; Thomsen TH; Floridon C; Smith K; Kejling K; Tornoe I; Crouch EC; Holmskov U
    Mol Immunol; 2009 Sep; 46(15):3060-9. PubMed ID: 19577304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.